Vascular risk factors: A ticking time bomb to alzheimer's disease

American Journal of Alzheimer's Disease and other Dementias

Volumn 28, Issue 6, 2013, Pages 551-559

  De La Torre, Jack C ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

aging; Alzheimer's; cerebral blood flow; hypoperfusion; neuroimaging; vascular risk factors

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; COGNITION; COGNITIVE DEFECT; HEMODYNAMICS; HUMAN; NEUROIMAGING; POSTERIOR CINGULATE; PRECUNEUS; RISK FACTOR;

AGING; ALZHEIMER'S; CEREBRAL BLOOD FLOW; HYPOPERFUSION; NEUROIMAGING; VASCULAR RISK FACTORS;

AGED; AGING; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; HOMEOSTASIS; HUMANS; RISK FACTORS;

EID: 84883317699     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513494457     Document Type: Article

References (99)

1. Buxton R Introduction to Functional Magnetic Resonance Imaging: Principles and Techniques. Cambridge, England: Cambridge University Press ; 2002 :
2. Leenders KL, Perani D, Lammertsma AA, et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age.. Brain.. 2009 ; 113 (pt 1). 27-47
3. Pantano P, Baron JC, Lebrun-Grandie P, Duquesnoy N, Bousser MG, Comar D. Regional cerebral blood flow and oxygen consumption in human aging. Stroke. 1994 ; 15 (4). 635-641
4. Zou Q, Wu CW, Stein EA, Zang Y, Yang Y. Static and dynamic characteristics of cerebral blood flow during the resting state. Neuroimage. 2009 ; 48 (3). 515-524
5. Gur RC, Gur RE, Obrist WD, Skolnick BE, Reivich M.. Age and regional cerebral blood flow at rest and during cognitive activity.. Arch Gen Psychiatry. 1987 ; 44 (7). 617-621 (Pubitemid 17099790)
6. Creasey H, Rapoport SI. The aging human brain. Ann Neurol. 1985 ; 17 (1). 2-10 (Pubitemid 15156043)
7. Rapp PR, Amaral DG. Individual differences in the cognitive and neurobiological consequences of normal aging. Trends Neurosci. 1992 ; 15 (9). 340-345
8. Grady CL, McIntosh AR, Bookstein F, Horwitz B, Rapoport SI, Haxby JV. Age-related changes in regional cerebral blood flow during working memory for faces. Neuroimage. 1998 ; 8 (4). 409-425 (Pubitemid 28545939)
9. Jacewicz M, Kiessling M, Pulsinelli WA. Selective gene expression in focal cerebral ischemia. J Cereb Blood Flow Metab. 1986 ; 6 (3). 263-272 (Pubitemid 16028928)
10. Heiss WD. Ischemic penumbra: evidence from functional imaging in man. J Cereb Blood Flow Metab. 2000 ; 20 (9). 1276-1293
11. Astrup J, Siesjo BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981 ; 12 (6). 723-725 (Pubitemid 12227362)
12. Branston NM, Strong AJ, Symon L.. Extracellular potassium activity, evoked potential and tissue blood flow. Relationships during progressive ischaemia in baboon cerebral cortex. J Neurol Sci. 1977 ; 32 (3). 305-321 (Pubitemid 8109810)
13. Wise RJ, Bernardi S, Frackowiak RS, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke. Brain. 1983 ; 106 (pt 1). 197-222
14. Kalimo H, Olsson Y, Paljari L, Soderfeldt B. Structural changes in brain tissue under hypoxic-ischemic conditions. J Cereb Blood Flow Metab. 1982 ; 2 (suppl 1). S19 - S22
15. Cross JL, Meloni BP, Bakker AJ, Lee S, Knuckey NW. Modes of neuronal calcium entry and homeostasis following cerebral ischemia. Stroke Res Treat. 2010 ; 316862: 2010
16. Lipton P. Ischemic cell death in brain neurons. Physiol Rev. 1999 ; 79 (4). 1431-1568 (Pubitemid 29473320)
17. de la Torre JC. The vascular hypothesis of Alzheimer's disease: bench to bedside and beyond. Neurodegener Dis. 2010 ; 7 (1-3). 116-121
18. Lund CG, Aamodt AH, Russell D. Patient selection for intra-arterial cerebral revascularization in acute ischemic stroke. Acta Neurol Scand Suppl. 2013 ; 196: 65-68
19. Lo EH. A new penumbra: transitioning from injury into repair after stroke. Nat Med. 2008 ; 14 (5). 497-500 (Pubitemid 351655209)
20. Baron JC. Mapping the ischaemic penumbra with PET: a new approach. Brain. 2001 ; 124 (pt 1). 2-4
21. Brumm KP, Perthen JE, Liu TT, Haist F, Ayalon L, Love T. An arterial spin labeling investigation of cerebral blood flow deficits in chronic stroke survivors. Neuroimage. 2010 ; 51 (3). 995-1005
22. Fisher M, Bastan B. Identifying and utilizing the ischemic penumbra. Neurology. 2012 ; 79 (13 suppl 1). S79 - S85
23. Devos D, Sevin M, De Gaalon S, Lintia-Gaultier A, Guillon B. Management of ischemic stroke in the hyperacute phase. Panminerva Med. 2013 ; 55 (1). 59-78
24. de la Torre JC, Fortin T, Park GA, Pappas BA, Richard MT. Brain blood flow restoration 'rescues' chronically damaged rat CA1 neurons. Brain Res. 1993 ; 623 (1). 6-15 (Pubitemid 23267383)
25. Borroni B, Tiberio G, Bonardelli S, et al. Is mild vascular cognitive impairment reversible? Evidence from a study on the effect of carotid endarterectomy. Neurol Res. 2004 ; 26 (5). 594-597 (Pubitemid 38879245)
26. Carnevale D, Mascio G, D'Andrea I, et al. Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension. 2012 ; 60 (1). 188-197
27. Goldsmith HS, Wu W, Zhong J, Edgar M.. Omental transposition to the brain as a surgical method for treating Alzheimer's disease. Neurol Res. 2003 ; 25 (6). 625-634 (Pubitemid 37087607)
28. Poels MM, Ikram MA, Vernooij MW, et al. Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008 ; 28 (10). 1652-1655
29. de la Torre JC, Mussivand T. Can disturbed brain microcirculation cause Alzheimer's disease?. Neurol Res. 1993 ; 15 (3). 146-153 (Pubitemid 23166998)
30. Marshall RS, Lazar RM, Pile-Spellman J, et al. Recovery of brain function during induced cerebral hypoperfusion. Brain. 2001 ; 124 (pt 6). 1208-1217 (Pubitemid 32510388)
31. Duan W, Chun-Qing Z, Zheng J, Gui L, Huang HQ, Chen KN. Relief of carotid stenosis improves impaired cognition in a rat model of chronic cerebral hypoperfusion. Acta Neurobiol Exp (Wars). 2011 ; 71 (2). 233-243
32. Yamane Y, Ishii K, Shimizu K, et al. Global cerebral hypoperfusion in a patient with transient global amnesia. J Comput Assist Tomogr. 2008 ; 32 (3). 415-417
33. Roy CS, Sherrington CS. On the regulation of the blood-supply of the brain. J Physiol. 1890 ; 11 (1-2). 85-92
34. Ingvar DH, Risberg J.. Influence of mental activity upon regional cerebral blood flow in man. A preliminary study. Acta Neurol Scand Suppl. 1965 ; 41 (suppl 14). 183-186
35. Chen Y, Wolk DA, Reddin JS, et al. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology. 2011 ; 77 (22). 1977-1985
36. de la Torre JC, Cada A, Nelson N, Davis G, Sutherland RJ, Gonzalez-Lima F. Reduced cytochrome oxidase and memory dysfunction after chronic brain ischemia in aged rats. Neurosci Lett. 1997 ; 223 (3). 165-168 (Pubitemid 27110324)
37. de la Torre JC, Fortin T, Park GA, et al. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Res. 1992 ; 582 (2). 186-195
38. de la Torre JC, Fortin T, Park GA, et al. Aged but not young rats develop metabolic, memory deficits after chronic brain ischemia. Neurol Res. 1992 ; 14 (suppl 2). 177-180
39. de la Torre JC. Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis. Neurobiol Aging. 2000 ; 21 (2). 331-342 (Pubitemid 30387092)
40. de la Torre JC. Hemodynamics of deformed microvessels in Alzheimer's disease brain. Ann N Y Acad Sci. 1997 ; 826: 75-91
41. Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet. 1997 ; 349 (9046). 151-154 (Pubitemid 27039193)
42. Skoog I, Lernfelt B, Landahl S, et al. 15-Year longitudinal study of blood pressure and dementia. Lancet. 1996 ; 347 (9009). 1141-1145 (Pubitemid 126512042)
43. Yarchoan M, Xie SX, Kling MA, et al. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain. 2012 ; 135 (pt 12). 3749-3756
44. Goldstein FC, Levey AI, Steenland NK. High blood pressure and cognitive decline in mild cognitive impairment. J Am Geriatr Soc. 2013 ; 61 (1). 67-73
45. Luzzi S, Vella L, Bartolini M, Provinciali L, Silvestrini M. Atherosclerosis in the evolution of Alzheimer's disease: can treatment reduce cognitive decline?. J Alzheimers Dis. 2010 ; 20 (3). 893-901
46. Orsucci D, Mancuso M, Ienco EC, Simoncini C, Siciliano G, Bonuccelli U. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease. Curr Neurovasc Res. 2013 ; 10 (1). 76-80
47. Polidori MC, Pientka L, Mecocci P. A review of the major vascular risk factors related to Alzheimer's disease. J Alzheimers Dis. 2012 ; 32 (3). 521-530
48. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics.. Lancet Neurol.. 2004 ; 3 (3). 184-190 (Pubitemid 38232669)
49. Pase MP. Modifiable vascular markers for cognitive decline and dementia: the importance of arterial aging and hemodynamic factors. J Alzheimers Dis. 2012 ; 32 (3). 653-663
50. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev. 2000 ; 34 (3). 119-136
51. Nitrini R, Buchpiguel CA, Caramelli P, et al. SPECT in Alzheimer's disease: features associated with bilateral parietotemporal hypoperfusion. Acta Neurol Scand. 2000 ; 101 (3). 172-176 (Pubitemid 30112297)
52. de la Torre JC. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis. 2012 ; 32 (3). 553-567
53. Ishii K, Sasaki M, Yamaji S, Sakamoto S, Maeda K. Cerebral blood flow changes in the primary motor and premotor cortices during hyperventilation. Ann Nucl Med. 1998 ; 12 (1). 29-33 (Pubitemid 28182614)
54. Johnson NA, Jahng GH, Weiner MW, et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005 ; 234 (3). 851-859 (Pubitemid 40250829)
55. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis. 2010 ; 20 (3). 871-880
56. Arnaiz E, Jelic V, Almkvist O, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport. 2001 ; 12 (4). 851-855 (Pubitemid 32222729)
57. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?. Neurology. 2003 ; 60 (8). 1374-1377 (Pubitemid 36461002)
58. Huang C, Wahlund LO, Almkvist O, et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage. 2003 ; 19 (3). 1137-1144 (Pubitemid 36918251)
59. Codispoti KE, Beason-Held LL, Kraut MA, et al. Longitudinal brain activity changes in asymptomatic Alzheimer disease. Brain Behav. 2012 ; 2 (3). 221-230
60. Arriagada PV, Growdon JH, Hedley-White ET, Hyman B. Neurofibrillar tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992 ; 42 (3 pt 1). 631-639
61. Bennett DA, Schneider JA, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 ; 66 (12). 1837-1844 (Pubitemid 44049813)
62. Price JL, McKeel DW, Buckles VD, et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging. 2009 ; 30 (7). 1026-1036
63. Gomez-Isla T, Hollister R, West H, et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997 ; 41 (1). 17-24 (Pubitemid 27057088)
64. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol. 1999 ; 58 (4). 376-388 (Pubitemid 29187900)
65. Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.. Neurobiol Aging. 2010 ; 31 (8). 1275-1283
66. Giannakopoulos P, Herrmann FR, Bussière T, et al. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology. 2003 ; 60 (9). 1495-1500 (Pubitemid 36559525)
67. Rodrigue KM, Kennedy KM, Park DC. Beta-amyloid deposition and the aging brain. Neuropsychol Rev. 2009 ; 19 (4). 436-450
68. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001 ; 357 (9251). 169-175
69. Velliquette RA, O'Connor T, Vassar R. Energy inhibition elevates beta secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J Neurosci. 2005 ; 25 (47). 10874-10883 (Pubitemid 41692617)
70. Sun X, Bromley-Brits K, Song W. Regulation of β-site APP-cleaving enzyme 1 gene expression and its role in Alzheimer's disease. J Neurochem. 2012 ; 120 (suppl 1). 62-70
71. Koike MA, Green KN, Blurton-Jones M, Laferla FM. Oligemic hypoperfusion differentially affects tau and amyloid-{beta}. Am J Pathol. 2010 ; 177 (1). 300-310
72. Drzezga A, Lautenschlager N, Siebner H, et al. Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging. 2003 ; 30 (8). 1104-1113 (Pubitemid 36988222)
73. Shaffer JL, Petrella JR, Sheldon FC, et al. Alzheimer's Disease Neuroimaging Initiative. Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.. Radiology. 2013 ; 266 (2). 583-591
74. Meier-Ruge WA, Bertoni-Freddari C. Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and trauma-induced dementia of the Alzheimer type. Ann N Y Acad Sci. 1997 ; 826: 229-241 (Pubitemid 27478044)
75. Toussaint PJ, Perlbarg V, Bellec P, et al. Benali, for the Alzheimer's Disease Neuroimaging Initiative. Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer's disease using conjoint univariate and independent component analyses.. Neuroimage. 2012 ; 63 (2). 936-946
76. Küntzelmann A, Guenther T, Haberkorn U, et al. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization. Neurosci Lett. 2013 ; 534: 12-17
77. Wolk DA, Detre JA. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr Opin Neurol. 2012 ; 25 (4). 421-428
78. Musiek ES, Chen Y, Korczykowski M, et al. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement. 2012 ; 8 (1). 51-59
79. Paulson OB, Hasselbalch SG, Rostrup E, Knudsen GM, Pelligrino D. Cerebral blood flow response to functional activation. J Cereb Blood Flow Metab. 2010 ; 30 (1). 2-14
80. Buxton RB, Frank LR. A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J Cereb Blood Flow Metab. 1997 ; 17 (1). 64-72 (Pubitemid 27014909)
81. Rocher AB, Chapon F, Blaizot X, Baron JC, Chavoix C. Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons. Neuroimage. 2004 ; 20 (3). 1894-1898 (Pubitemid 37468295)
82. Mosconi L, Tsui WH, De Santi S, et al. Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology. 2005 ; 64 (11). 1860-1867 (Pubitemid 40800698)
83. Okonkwo OC, Xu G, Oh JM, et al Cereb Cortex. 2012 :
84. Mosconi L, Mistur R, Switalski R, et al. FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2009 ; 36 (5). 811-822
85. Haroutunian V, Hoffman LB, Beeri MS. Is there a neuropathology difference between mild cognitive impairment and dementia?. Dialogues Clin Neurosci. 2009 ; 11 (12). 171-179
86. Wolf H, Hensel A, Kruggel F, et al. Structural correlates of mild cognitive impairment. Neurobiol Aging. 2004 ; 25 (7). 913-924 (Pubitemid 38813171)
87. Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005 ; 57 (6). 789-794 (Pubitemid 40798616)
88. de la Torre JC. Critical threshold cerebral hypoperfusion causes Alzheimer's disease. Acta Neuropathol. 1999 ; 98 (1). 1-8 (Pubitemid 29278302)
89. Mazza M, Marano G, Traversi G, Bria P, Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis. 2011 ; 23 (3). 375-389
90. Roher AE, Debbins JP, Malek-Ahmadi M, et al. Cerebral blood flow in Alzheimer's disease. Vasc Health Risk Manag. 2012 ; 8: 599-611
91. Kalaria RN, Akinyemi R, Ihara M. Does vascular pathology contribute to Alzheimer changes?. J Neurol Sci. 2012 ; 322 (1-2). 141-147
92. Park KW, Yoon HJ, Kang DY, Kim BC, Kim S, Kim JW. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Psychiatry Res. 2012 ; 203 (2-3). 201-206
93. Chao LL, Pa J, Duarte A, et al. Patterns of cerebral hypoperfusion in amnestic and dysexecutive MCI. Alzheimer Dis Assoc Disord. 2009 ; 23 (3). 245-252
94. Waldstein SR, Rice SC, Thayer JF, Najjar SS, Scuteri A, Zonderman AB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore Longitudinal Study of Aging. Hypertension. 2008 ; 51 (1). 99-104 (Pubitemid 350307110)
95. Inoue K, Meguro K, Akanuma K, Meguro M, Yamaguchi S, Fukuda H. Impaired memory and executive function associated with decreased medial temporal and prefrontal blood flow in Clinical Dementia Rating 0.5 status: the Osaki-Tajiri project. Psychogeriatrics. 2012 ; 12 (1). 27-33
96. Clerici F, Caracciolo B, Cova I, et al. Does vascular burden contribute to the progression of mild cognitive impairment to dementia?. Dement Geriatr Cogn Disord. 2012 ; 34 (3-4). 235-243
97. Silvestrini M, Viticchi G, Altamura C, Luzzi S, Balucani C, Vernieri F. Cerebrovascular assessment for the risk prediction of Alzheimer's disease. J Alzheimers Dis. 2012 ; 32 (3). 689-698
98. Richard F, Pasquier F. Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?. J Alzheimers Dis. 2012 ; 32 (3). 765-772
99. Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol. 1997 ; 42 (1). 85-94 (Pubitemid 27304784)